These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17110501)

  • 1. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir.
    Imaoka T; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
    Mol Pharmacol; 2007 Feb; 71(2):619-27. PubMed ID: 17110501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil.
    Ming X; Thakker DR
    Biochem Pharmacol; 2010 Feb; 79(3):455-62. PubMed ID: 19735648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tubular transporters OAT1 and MRP2 and clearance of adefovir].
    Servais A; Lechat P; Zahr N; Urien S; Aymard G; Jaudon MC; Deray G; Isnard Bagnis C
    Nephrol Ther; 2005 Nov; 1(5):296-300. PubMed ID: 16895698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one).
    Mizuno N; Takahashi T; Kusuhara H; Schuetz JD; Niwa T; Sugiyama Y
    Drug Metab Dispos; 2007 Nov; 35(11):2045-52. PubMed ID: 17682070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney.
    Ci L; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
    Mol Pharmacol; 2007 Jun; 71(6):1591-7. PubMed ID: 17344354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of active renal tubular efflux of tenofovir.
    Ray AS; Cihlar T; Robinson KL; Tong L; Vela JE; Fuller MD; Wieman LM; Eisenberg EJ; Rhodes GR
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3297-304. PubMed ID: 17005808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
    Cundy KC
    Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration.
    Kearney BP; Ramanathan S; Cheng AK; Ebrahimi R; Shah J
    J Clin Pharmacol; 2005 Aug; 45(8):935-40. PubMed ID: 16027404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na⁺/H⁺ exchanger regulatory factor 3 is critical for multidrug resistance protein 4-mediated drug efflux in the kidney.
    Park J; Kwak JO; Riederer B; Seidler U; Cole SP; Lee HJ; Lee MG
    J Am Soc Nephrol; 2014 Apr; 25(4):726-36. PubMed ID: 24436471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4.
    Janke D; Mehralivand S; Strand D; Gödtel-Armbrust U; Habermeier A; Gradhand U; Fischer C; Toliat MR; Fritz P; Zanger UM; Schwab M; Fromm MF; Nürnberg P; Wojnowski L; Closs EI; Lang T
    Hum Mutat; 2008 May; 29(5):659-69. PubMed ID: 18300232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
    Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
    J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4).
    Ose A; Ito M; Kusuhara H; Yamatsugu K; Kanai M; Shibasaki M; Hosokawa M; Schuetz JD; Sugiyama Y
    Drug Metab Dispos; 2009 Feb; 37(2):315-21. PubMed ID: 19029202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters.
    Kohler JJ; Hosseini SH; Green E; Abuin A; Ludaway T; Russ R; Santoianni R; Lewis W
    Lab Invest; 2011 Jun; 91(6):852-8. PubMed ID: 21403643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs.
    Cihlar T; Ho ES; Lin DC; Mulato AS
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):641-8. PubMed ID: 11563082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel nucleotide human immunodeficiency virus reverse transcriptase inhibitor GS-9148 with a low nephrotoxic potential: characterization of renal transport and accumulation.
    Cihlar T; Laflamme G; Fisher R; Carey AC; Vela JE; Mackman R; Ray AS
    Antimicrob Agents Chemother; 2009 Jan; 53(1):150-6. PubMed ID: 19001108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir.
    Laho T; Clarke JD; Dzierlenga AL; Li H; Klein DM; Goedken M; Micuda S; Cherrington NJ
    Biochem Pharmacol; 2016 Sep; 115():144-51. PubMed ID: 27381944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of Na+/H+ exchanger regulatory factor 1 increases expression and function of multidrug resistance protein 4.
    Hoque MT; Cole SP
    Cancer Res; 2008 Jun; 68(12):4802-9. PubMed ID: 18559527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide.
    Hasegawa M; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
    J Am Soc Nephrol; 2007 Jan; 18(1):37-45. PubMed ID: 17135398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage.
    Belinsky MG; Guo P; Lee K; Zhou F; Kotova E; Grinberg A; Westphal H; Shchaveleva I; Klein-Szanto A; Gallo JM; Kruh GD
    Cancer Res; 2007 Jan; 67(1):262-8. PubMed ID: 17210706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins.
    Akanuma S; Hosoya K; Ito S; Tachikawa M; Terasaki T; Ohtsuki S
    J Pharmacol Exp Ther; 2010 Jun; 333(3):912-9. PubMed ID: 20194529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.